Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04288089 |
| Title | A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | H3 Biomedicine Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Florida Cancer Specialists South - SCRI - PPDS | Sarasota | Florida | 34232 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Saint Luke's Cancer Institute | Kansas City | Missouri | 64111 | United States | Details | |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | United States | Details | |
| Tennessee Oncology, PLLC - SCRI - PPDS | Nashville | Tennessee | 37203 | United States | Details | |
| Royal Marsden NHS Foundation Trust | London | United Kingdom | Details | |||
| Sarah Cannon Research Institute UK - SCRI | London | United Kingdom | Details | |||
| Royal Marsden NHS Foundation Trust | Sutton | United Kingdom | Details |